These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34399146)

  • 1. Multimodal retinal imaging to detect and understand Alzheimer's and Parkinson's disease.
    Moons L; De Groef L
    Curr Opin Neurobiol; 2022 Feb; 72():1-7. PubMed ID: 34399146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease.
    Casciano F; Zauli E; Celeghini C; Caruso L; Gonelli A; Zauli G; Pignatelli A
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal thinning of inner sub-layers is associated with cortical atrophy in a mouse model of Alzheimer's disease: a longitudinal multimodal in vivo study.
    Chiquita S; Campos EJ; Castelhano J; Ribeiro M; Sereno J; Moreira PI; Castelo-Branco M; Ambrósio AF
    Alzheimers Res Ther; 2019 Nov; 11(1):90. PubMed ID: 31722748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal imaging in Alzheimer's and neurodegenerative diseases.
    Snyder PJ; Alber J; Alt C; Bain LJ; Bouma BE; Bouwman FH; DeBuc DC; Campbell MCW; Carrillo MC; Chew EY; Cordeiro MF; Dueñas MR; Fernández BM; Koronyo-Hamaoui M; La Morgia C; Carare RO; Sadda SR; van Wijngaarden P; Snyder HM
    Alzheimers Dement; 2021 Jan; 17(1):103-111. PubMed ID: 33090722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls.
    Nunes A; Silva G; Duque C; Januário C; Santana I; Ambrósio AF; Castelo-Branco M; Bernardes R
    PLoS One; 2019; 14(6):e0218826. PubMed ID: 31226150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.
    Jakimovski D; Bergsland N; Dwyer MG; Hagemeier J; Ramasamy DP; Szigeti K; Guttuso T; Lichter D; Hojnacki D; Weinstock-Guttman B; Benedict RHB; Zivadinov R
    Neurobiol Aging; 2020 Jun; 90():84-92. PubMed ID: 32147244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal imaging biomarkers of neurodegenerative diseases.
    Christinaki E; Kulenovic H; Hadoux X; Baldassini N; Van Eijgen J; De Groef L; Stalmans I; van Wijngaarden P
    Clin Exp Optom; 2022 Mar; 105(2):194-204. PubMed ID: 34751086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.
    Chrysou A; Jansonius NM; van Laar T
    Parkinsonism Relat Disord; 2019 Jul; 64():40-49. PubMed ID: 31054866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal α-synuclein deposits in Parkinson's disease patients and animal models.
    Veys L; Vandenabeele M; Ortuño-Lizarán I; Baekelandt V; Cuenca N; Moons L; De Groef L
    Acta Neuropathol; 2019 Mar; 137(3):379-395. PubMed ID: 30721408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.
    Uzuegbunam BC; Librizzi D; Hooshyar Yousefi B
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.
    Pillai JA; Bermel R; Bonner-Jackson A; Rae-Grant A; Fernandez H; Bena J; Jones SE; Ehlers JP; Leverenz JB
    Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):430-6. PubMed ID: 26888864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.
    Donatelli G; Ceravolo R; Frosini D; Tosetti M; Bonuccelli U; Cosottini M
    Curr Neurol Neurosci Rep; 2018 Apr; 18(6):31. PubMed ID: 29679161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease.
    More SS; Beach JM; McClelland C; Mokhtarzadeh A; Vince R
    ACS Chem Neurosci; 2019 Nov; 10(11):4492-4501. PubMed ID: 31603648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
    Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
    Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology.
    Singh S
    Int J Neurosci; 2020 Mar; 130(3):251-261. PubMed ID: 31575316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's Disease: What Can Retinal Imaging Tell Us?
    Di Pippo M; d'Agostino S; Ruggeri F; Carrozzi C; Fasciolo D; Abdolrahimzadeh S
    J Integr Neurosci; 2024 Jan; 23(1):23. PubMed ID: 38287853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease.
    Zhang Y; Wang Y; Shi C; Shen M; Lu F
    Transl Neurodegener; 2021 Feb; 10(1):6. PubMed ID: 33517891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 123I-iodoamphetamine.
    Tachibana H; Kawabata K; Tomino Y; Sugita M; Fukuchi M
    Dementia; 1993; 4(6):334-41. PubMed ID: 8136897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.